marketing 第1页

Analysis of clinical use of post-marketing hospital centralized monitoring of Xiyanping injection Establishment of model of traditional Chinese medicine injections post-marketing safety monitoring Exploration of how to formulate guidelines on post-marketing traditional Chinese medicine surveillance material resources for sustainable development Research on foreign countries‘laws and regulations on surveillance and  reporting of postmarketing drugs adverse reactions Clinical safety re-evaluation of post-marketing Chinese materia medica on syndrome Preliminary analysis of ginseng industry in Wisconsin Clinical effect of Kudiezi injection on renal function based on propensity score Establish research model of post-marketing clinical safety evaluation for Chinese patent medicine Design process and key points of clinical effectiveness re-evaluation on postmarketing herbs Sample size calculation in clinical post-marketing evaluation of traditional Chinese medicine Post-marketing clinical study of traditional Chinese medicine——lessons learned from comprehensive evaluation of Fufang Zaoren capsule Expert consensus post-marketing evaluation scheme to detect immunotoxicity of Chinese medicine in clinical populations (draft version for comments) Technical specifications for post-marketing pharmacoeconomic evaluation of Chinese medicine(draft version for comments) Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine(draft version for comments) A discussion of key issues on postmarketing reevaluation of Chinese medicine Postmarketing herbs clinical evaluation should concernabout re-evaluating symptoms Thought on several problems of clinical revaluationofpost-marketing herb research Discussion on methods of sample size estimation in conducting clinical reevaluation of postmarketing Chinese medicine Post-marketing re-evaluation of Kudiezi injection study on early treatment in patients with ischemic stroke Post-marketed re-evaluation of fleabane injection and Dengzhan Shengmai capsule study on treatment in patients with ischemic stroke Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world Thought on several problems of post-marketing herbs clinical evaluation in special populations Basic requirements on post-marketing clinical re-evaluation of Chinese medicine and phase Ⅳ clinical trials Process and key points of clinical literature evaluation of post-marketing traditional Chinese medicine Application of Markov model in post-marketing pharmacoeconomic evaluation of traditional Chinese medicine Research about re-evaluation of screening of traditonal Chinese medicine symptoms item of post-marketing medicine Xuezhikang Application of regular expression in extracting key information from Chinese medicine literatures about re-evaluation of post-marketing surveillance Opportunity and challenge of post-marketing evaluation of traditional Chinese medicine Taking evaluation of post-marketing as point of cut-in to promote systematic research of traditional Chinese medicine Research and practice about risk control of Shenfu injection Literature review on premarketing and postmarketing evidence of Xiyanping injection Study of post marketing safety reevaluation of Shenqi Fuzheng injection Post-marketing reevaluation for potential quality risk and quality control in clinical application of traditional Chinese medicines Discussion on development of four diagnostic information scale for clinical re-evaluation of postmarketing herbs Survey on Xiaoke pill treating diabetes mellitus in small cities‘ Chinese medicine hospital for post-marketing surveillance Literature review of post-marketing clinical evaluation of Xiaoke pill Simulation of dry matter partitioning and marketing date of greenhouseSimulation of dry matter partitioning and marketing date of greenhouse Phalaenopsis aphrodita Rchb. F. flower “Re-evaluation upon suspected event” is an approach for post-marketing clinical study： lessons from adverse drug events related to Bupleuri Radix preparations Methodology on revaluation of syndrome therapeutic effect of post-marketing Chinese materia medica